Company Directory / biotechnology
PrivateFor profitbiotechnologySan Francisco, United States
Mindstate Design Labs
Mindstate Design Labs is a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics.
- Founded
- 2021 5 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $12M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
5 years old.
Reach
Website ranked #7,452,540 in the world for traffic, about 766 visits a month.
What it does
BiotechnologyHealth CareTherapeutics
Funding, as listed
$12M currency not stated
- Rounds3
- LatestSeed, Jan 2023
- Investors21, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Mindstate Design Labs, field by field. Contact details are held but never shown.
The company
- Name
- Mindstate Design Labs
- Type
- For profit
- Status
- Private
- Founded
- 2021
- Founders
- Dillan DiNardo, Tom Ray
- Industry
- biotechnology
- Categories
- Biotechnology, Health Care, Therapeutics
Where
- City
- San Francisco
- Country
- United States
- Markets
- Great Lakes, Northeastern US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #7,452,540
- Monthly web visits
- 766
Funding, as listed
- Total
- 11,625,000 (currency not stated)
- Rounds
- 3
- Latest round
- Seed
- Latest round date
- Jan 2023
- Investors
- 21
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Mindstate Design Labs may be growing as it has progressed its first AI-derived psychedelic compound into clinical trials, which is a significant milestone for a preclinical-stage biotechnology company. This advancement into clinical trials indicates a transition from preclinical research to human testing, which can be a substantial investment in the company's research and development capabilities. Furthermore, the move to clinical trials could potentially lead to partnerships, increased funding opportunities, and a stronger position in the biotechnology and therapeutics industry.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
biotechnology in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.